Seveno Capital Invests in PointFit as Next-Generation Wearable Patch Signals a Break from Traditional Wearable Devices

Seveno Capital has made a strategic investment in PointFit, a Hong Kong-based startup developing a skin patch wearable for non-invasive, real-time biomarker monitoring through sweat, valuing the company at US $10 million. This marks Seveno Capital's first transaction from its new Hong Kong office and the inaugural deal led by new Partner Jean-Baptiste Roy.